Protein-Intrinsic and Signaling Network-Based Sources of Resistance to EGFR- And ErbB Family-Targeted Therapies in Head and Neck Cancer

Drug Resistance Updates - United States
doi 10.1016/j.drup.2011.08.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Molecularly Targeted Therapy for the Treatment Of head and Neck Cancer: A Review of the ErbB Family Inhibitors

OncoTargets and Therapy
OncologyPharmacology
2016English

Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer

International Journal of Medical Sciences
Medicine
2015English

Targeted Therapies in Cancer and Mechanisms of Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2014English

Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging

Clinical Cancer Research
Cancer ResearchOncology
2015English

Novel Chemoradiotherapy Regimens Incorporating Targeted Therapies in Locally Advanced Head and Neck Cancers

2012English

Therapy Resistance in Head and Neck Cancer Stem Cells

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Application of Molecular Targeted Therapies in the Treatment of Head and Neck Squamous Cell Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy